Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s):  LBLTF

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.


TSXV:LBL.H - Post by User

Comment by Nomoreshells4meon Jul 29, 2020 8:47am
78 Views
Post# 31335713

RE:RE:RE:Video - 3 months ago - Guy Cook gets IV treatment.

RE:RE:RE:Video - 3 months ago - Guy Cook gets IV treatment.
I'll add my 2 cents to the conversation. March/April I was having regular email exchanges with Guy. As time went by and I pressed him on certain positive/wishful things he said. He went silent. I reached out to Chad and we've gone back and forth. Yesterday after seeing the positive fb post from the psoriasis trial patient I messaged Chad and asked. Have you started enrolling patients in the psoriasis trial? He responded " Yes we have subjects enrolled and started in the psoriasis trial ". I then asked " Have subjects been enrolled and started in the COVID-19 trial?. His response was " I am not at liberty to give specifics on either trial. Only that they are ongoing. I pushed back and asked " You wrote: Yes we have trial subjects enrolled and started in the psoriasis trial. So my question: Do you have trial subjects enrolled and started in the COVID-19/ARDS trial? He has yet to answer me. My fear is that the COVID-19 trial is not a priority for them. We know they've had trouble recruiting patients for the study. My bigger fear is that it's collecting dust. Sure, there were investors who bought on the March 17th announcement but that's the way it goes. They want to build a business that will be around long after covid. ( that's actually what Chad wrote in another message to me). This was a 2 cent stock before the COVID-19 trial announcement and now it's run to .20 and back to 4cents. Without the possibility of a announcement of the repurposing of Amnioboost for ARDS in COVID-19 patients. This will be a 5 cent stock for the foreseeable future. Not at all what I bought in for. Any comments on this? Does anyone have any information that the COVID-19 trial is front and center in Guys mind.
<< Previous
Bullboard Posts
Next >>